{"id":"https://openalex.org/W2184783229","doi":null,"title":"New advances in peptide receptor radionuclide therapy.","display_name":"New advances in peptide receptor radionuclide therapy.","publication_year":2002,"publication_date":"2002-05-01","ids":{"openalex":"https://openalex.org/W2184783229","mag":"2184783229","pmid":"https://pubmed.ncbi.nlm.nih.gov/11994523"},"language":"en","primary_location":{"id":"pmid:11994523","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11994523","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","raw_type":"Comment"},"volume":null,"type":"letter","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5040369608","display_name":"Marion de Jong","orcid":"https://orcid.org/0000-0002-6725-1854","observed_orcids":["https://orcid.org/0000-0002-6725-1854","https://orcid.org/0000-0003-2247-332X"]},"institutions":[{"id":"https://openalex.org/I2801952686","display_name":"Erasmus MC","ror":"https://ror.org/018906e22","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2801952686"]}],"countries":["NL"],"is_corresponding":true,"raw_author_name":"Marion de Jong","raw_affiliation_strings":["Department of Nuclear Medicine, Erasmus University Medical Center Rotterdam Rotterdam, The Netherlands. dejong@nuge.azr.nl"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Nuclear Medicine, Erasmus University Medical Center Rotterdam Rotterdam, The Netherlands. dejong@nuge.azr.nl","institution_ids":["https://openalex.org/I2801952686"]}]},{"author_position":"last","author":{"id":null,"display_name":"Eric Krenning","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Eric Krenning","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5040369608"],"corresponding_institution_ids":["https://openalex.org/I2801952686"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":87,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"43","issue":"5","first_page":"617","last_page":"20"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.861299991607666,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.861299991607666,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10754","display_name":"Neuroendocrine Tumor Research Advances","score":0.13570000231266022,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12505","display_name":"Peptidase Inhibition and Analysis","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/peptide-receptor-radionuclide-therapy","display_name":"peptide receptor radionuclide therapy","score":1.0},{"id":"https://openalex.org/keywords/somatostatin-receptors","display_name":"somatostatin receptors","score":0.8610000014305115},{"id":"https://openalex.org/keywords/radiolabeled-somatostatin-analogs","display_name":"radiolabeled somatostatin analogs","score":0.9480000138282776},{"id":"https://openalex.org/keywords/octreotide","display_name":"octreotide","score":0.972000002861023},{"id":"https://openalex.org/keywords/dota","display_name":"DOTA","score":0.3059999942779541},{"id":"https://openalex.org/keywords/yttrium-90","display_name":"yttrium-90","score":0.875},{"id":"https://openalex.org/keywords/111in","display_name":"indium-111","score":0.9769999980926514},{"id":"https://openalex.org/keywords/tumor-imaging","display_name":"tumor imaging","score":0.5329999923706055}],"concepts":[{"id":"https://openalex.org/C3017732841","wikidata":"https://www.wikidata.org/wiki/Q25098597","display_name":"Peptide receptor","level":3,"score":0.5008721351623535},{"id":"https://openalex.org/C158973077","wikidata":"https://www.wikidata.org/wiki/Q192900","display_name":"Radionuclide","level":2,"score":0.4923361539840698},{"id":"https://openalex.org/C2993559085","wikidata":"https://www.wikidata.org/wiki/Q2126444","display_name":"Radionuclide therapy","level":2,"score":0.48343977332115173},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.32498013973236084},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.2540953755378723},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.23395699262619019},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.08300444483757019},{"id":"https://openalex.org/C62520636","wikidata":"https://www.wikidata.org/wiki/Q944","display_name":"Quantum mechanics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007668","descriptor_name":"Kidney","qualifier_ui":"Q000528","qualifier_name":"radiation effects","is_major_topic":false},{"descriptor_ui":"D015021","descriptor_name":"Yttrium Radioisotopes","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D015021","descriptor_name":"Yttrium Radioisotopes","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015282","descriptor_name":"Octreotide","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D015282","descriptor_name":"Octreotide","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D018358","descriptor_name":"Neuroendocrine Tumors","qualifier_ui":"Q000532","qualifier_name":"radiotherapy","is_major_topic":true},{"descriptor_ui":"D019275","descriptor_name":"Radiopharmaceuticals","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":6,"locations":[{"id":"pmid:11994523","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11994523","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of nuclear medicine : official publication, Society of Nuclear Medicine","raw_type":"Comment"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.531.4398","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.531.4398","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://jnm.snmjournals.org/content/43/5/617.full.pdf","raw_type":"text"},{"id":"pmh:eur:oai:pure.eur.nl:publications/ab0e319a-c22f-47cb-ac95-5c3bdaeb0c25","doi":null,"is_oa":false,"landing_page_url":"https://pure.eur.nl/en/publications/ab0e319a-c22f-47cb-ac95-5c3bdaeb0c25","pdf_url":null,"source":{"id":"https://openalex.org/S4306401266","display_name":"EUR Research Repository (Erasmus University Rotterdam)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I913958620","host_organization_name":"Erasmus University Rotterdam","host_organization_lineage":["https://openalex.org/I913958620"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal of Nuclear Medicine, 43(5), 617 - 620. Society of Nuclear Medicine and Molecular Imaging","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:pure.eur.nl:openaire_cris_publications/ab0e319a-c22f-47cb-ac95-5c3bdaeb0c25","doi":null,"is_oa":false,"landing_page_url":"https://pure.eur.nl/en/publications/ab0e319a-c22f-47cb-ac95-5c3bdaeb0c25","pdf_url":null,"source":{"id":"https://openalex.org/S4306401266","display_name":"EUR Research Repository (Erasmus University Rotterdam)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I913958620","host_organization_name":"Erasmus University Rotterdam","host_organization_lineage":["https://openalex.org/I913958620"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Jong, M & Krenning, E 2002, 'New advances in peptide receptor radionuclide therapy', Journal of Nuclear Medicine, vol. 43, no. 5, pp. 617-620.","raw_type":"info:eu-repo/semantics/article"},{"id":"mag:2184783229","doi":null,"is_oa":false,"landing_page_url":"http://jnm.snmjournals.org/content/43/5/617.full.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},{"id":"mag:2337767463","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11994523","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":27,"referenced_works":["https://openalex.org/W136083521","https://openalex.org/W1510727472","https://openalex.org/W1633392123","https://openalex.org/W1700476826","https://openalex.org/W1905043692","https://openalex.org/W1935825021","https://openalex.org/W1955439486","https://openalex.org/W1966024289","https://openalex.org/W1982055976","https://openalex.org/W1985061998","https://openalex.org/W2005674134","https://openalex.org/W2012600554","https://openalex.org/W2025697667","https://openalex.org/W2033460249","https://openalex.org/W2054096599","https://openalex.org/W2069387784","https://openalex.org/W2123859260","https://openalex.org/W2128876754","https://openalex.org/W2152279343","https://openalex.org/W2256938482","https://openalex.org/W2342561786","https://openalex.org/W2403493805","https://openalex.org/W2415299542","https://openalex.org/W2416732863","https://openalex.org/W2418492888","https://openalex.org/W3111275377","https://openalex.org/W4296766361"],"related_works":["https://openalex.org/W4245164678","https://openalex.org/W3188833677","https://openalex.org/W2737541065","https://openalex.org/W4408123932","https://openalex.org/W1591757299","https://openalex.org/W6986305944","https://openalex.org/W2143647916","https://openalex.org/W6986416367","https://openalex.org/W2435612632","https://openalex.org/W7120410038"],"abstract_inverted_index":{"receptors":[0,31],"are":[1,32,110],"useful":[2],"drug":[3],"targets":[4],"for":[5,27,36],"therapy":[6,61],"aimed":[7],"at":[8],"the":[9,45,105,120],"treatment":[10],"of":[11,14,29,38],"humoral":[12],"effects":[13],"certain":[15],"tumors.":[16],"Radiolabeled":[17],"somatostatin":[18,39,78],"an-alogs,":[19],"such":[20],"as":[21],"octreotide,":[22],"with":[23,53,91],"a":[24],"high":[25],"affinity":[26],"subtypes":[28],"these":[30,51,72],"successfully":[33],"being":[34,111],"applied":[35],"vi-sualization":[37],"receptor\u2013":[40],"positive":[41],"tumors":[42,80],"(1),":[43],"and":[44,66,99],"next":[46],"chal-lenge":[47],"was":[48,119],"to":[49,56,76,104],"label":[50],"peptides":[52],"therapeutic":[54,84],"radionuclides":[55],"perform":[57],"peptide":[58],"receptor":[59],"radionuclide":[60],"(PRRT).":[62],"Results":[63],"from":[64],"preclinical":[65],"clinical":[67],"multicenter":[68],"studies":[69,109],"show":[70],"that":[71],"radiolabeled":[73],"agents":[74],"used":[75,88,123],"treat":[77],"receptor\u2013positive":[79],"provide":[81],"an":[82],"effective":[83],"response":[85],"and,":[86],"when":[87],"in":[89],"conjunction":[90],"positively":[92],"charged":[93],"amino":[94],"acids,":[95],"reduce":[96],"kidney":[97],"uptake":[98],"therefore":[100],"prevent":[101],"potential":[102],"damage":[103],"kidneys.":[106],"Clinical":[107],"PRRT":[108],"performed":[112],"using":[113],"different":[114],"agents.":[115],"[111In-diethylenetriaminepentaacetic":[116],"acid":[117,130],"(DTPA)]-octreotide":[118],"first":[121],"analog":[122],"(2":[124],"\u2013":[125],"6),":[126],"followed":[127],"by":[128],"[90Y-dodecanetetraacetic":[129],"(DOTA),":[131]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":7},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":6}],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2016-06-24T00:00:00"}